A detailed history of Annapolis Financial Services, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Annapolis Financial Services, LLC holds 12 shares of AZN stock, worth $784. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12
Holding current value
$784
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

BUY
$76.67 - $87.62 $920 - $1,051
12 New
12 $0
Q2 2021

Aug 04, 2021

SELL
$48.42 - $60.18 $242 - $300
-5 Closed
0 $0
Q1 2021

May 06, 2021

BUY
$47.16 - $54.44 $235 - $272
5 New
5 $0

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $203B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Annapolis Financial Services, LLC Portfolio

Follow Annapolis Financial Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Annapolis Financial Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Annapolis Financial Services, LLC with notifications on news.